Study summary
A myasthenia gravis drug given around surgery eased symptoms in people with thymoma
What was tested
Efgartigimod, an antibody-lowering drug approved for myasthenia gravis, given around the time of thymoma surgery to people with thymoma-related myasthenia gravis. No comparison group.
What they found
- Muscle weakness improved quickly, including breathing and swallowing muscles.
- 10% had a myasthenic crisis after extended surgery.
What it means
About a third of people with thymoma have myasthenia gravis; safer surgery for them is a real need. A randomized trial is planned.
Last reviewed 2026-11-14 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.